Home/Filings/4/0001209191-21-041091
4//SEC Filing

Butt Tausif 4

Accession 0001209191-21-041091

CIK 0001340652other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 7:01 PM ET

Size

5.6 KB

Accession

0001209191-21-041091

Insider Transaction Report

Form 4
Period: 2021-06-14
Butt Tausif
EVP, Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-06-14+75,00075,000 total
    Exercise: $13.17Exp: 2031-06-14Common Stock (75,000 underlying)
Footnotes (2)
  • [F1]The option was granted on June 14, 2021, and 25% of the total number of shares of common stock subject to the option vests on June 14, 2022, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
  • [F2]Not applicable.

Issuer

ChemoCentryx, Inc.

CIK 0001340652

Entity typeother

Related Parties

1
  • filerCIK 0001845266

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 7:01 PM ET
Size
5.6 KB